SCHEMBL7497735

SCHEMBL7497735

Cn1c2cccc(Br)c2c2c(CBr)nn(-c3ccccc3)c(=O)c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.43
ADORA3 P0DMS8 2/20 0.39
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 4/20 0.37
TSHR P16473 3/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 2/20 0.37
MAPK1 P28482 1/20 0.37
RXFP1 Q9HBX9 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
HSD17B10 Q99714 2/20 0.36
POLB P06746 2/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
PAX8 Q06710 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7751594 0.87 TSPO (0.50) TSPOALDH1A1KMT2ATSHRKDM4E
SCHEMBL7498246 0.86 KDM4E (0.42) TSPOADORA3ALDH1A1KMT2ATSHR
SCHEMBL7495976 0.84 CDK1 (0.44) ADORA3ALDH1A1KMT2AKDM4EHPGD
SCHEMBL7496512 0.84 TSPO (0.47) TSPOALDH1A1KMT2ATSHRKDM4E
SCHEMBL7494763 0.81 TSPO (0.45) TSPOALDH1A1KMT2ATSHRKDM4E
SCHEMBL7496967 0.76 TSPO (0.60) TSPO
SCHEMBL7750505 0.70 TSPO (0.61) TSPOALDH1A1KMT2ATSHRKDM4E
SCHEMBL7495009 0.69 TSPO (0.46) TSPOKMT2ATSHRKDM4EHPGD
SCHEMBL7497415 0.68 KDM4E (0.41) TSPOALDH1A1KDM4EMAPK1MAPT
SCHEMBL600372 0.67 TSPO (0.78) TSPOALDH1A1KDM4ESMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000063-B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI SYNTHELABO (FR) 2002-10-23 EP disclosed
US-6262045-B1 TREATMENT OF ANXIETY; SLEEP DISORDER; EPILEPSY; SPASTICITY; MUSCLE CONTRACTURE OR AN EXTRAPYRAMIDAL SYNDROM; INDUCING OR MAINTAINING ANAESTHESIA SANOFI-SYNTHELABO (FR) 2001-07-17 US disclosed